// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Review of existing fertility preservation options and advice given to teenagers and young adults with haematological malignancies in the United Kingdom

N Elmusharaf - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Uncoupling of BCR internalisation and signalling in normal and chronic lymphocytic leukaemia B‐cells

E Coulter - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

L-Tyrosine

A phase III efficacy and safety study of the proposed rituximab biosimilar GP2013 versus rituximab in 629 patients with previously untreated advanced follicular lymphoma

W Jurczak - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

Rituximab biosimilar

A positive 18F‐FDG PET/CT scan at the end of R‐CHOP in diffuse large B cell lymphoma patients has a low positive predictive value for relapse

C Hildyard - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

Cyclophosphamide

Advanced Hodgkin lymphoma in the East of England Cancer Network: a 10‐year comparative analysis of outcomes for ABVD and escalated BEACOPP treated patients aged 16–59

A Collins - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

This study is the review and comparison of the histological reports of diagnostic samples of lymphoproliferative disorders over a span of one year (2014–2015) which were obtained after local and central review of the diagnostic specimens.

A Mohan - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

Methylprednisolone

Retrospective analysis of diffuse large B‐cell lymphoma referrals for autograft in the Thames Valley region

C Sweeney - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

The use of bone marrow aspirate and trephine as an investigative tool: an audit of practice at Heart of England Foundation Trust

R Pryor - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Congenital disorder

N/A

N/A

From the lab bench to the bedside – a novel approach to haematology registrar training using simulation

J Wolf - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Single hospital retrospective study of thrombopoetin receptor agonists (TPO‐RA) eltrombopag and romiplostim in chronic immune thrombocytopenia (cITP)

S Kundu - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Eltrombopag

Case report of eltrombopag in a pregnant women with Immune Thrombocytopenia Purpura (ITP)

K White - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Methylprednisolone

An audit of the diagnostic pathway for thrombocytosis in a large district general hospital

S Hebballi - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

Phase 2 diagnostic evaluation of the 3DHISTECH Slide Scanning Technology for Digitising Bone Marrow Slides

T Farren - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Haematology Heroes

N Kaur - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Methadone hydrochloride

An audit of requesting patterns for JAK2, JAK2 exon 12, Calreticulin and MPL in the South Yorkshire region over a 1 year period

E-W Toh - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Haematological profile of colorectal cancer patients at diagnosis: a single centre study

F Alibeygi - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

Single centre data on epidemiology and clinical management of myeloproliferative disease over a 12‐month period

J Tam - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Machine Learning to Predict the Likelihood of Acute Myocardial Infarction

Nicholas L Mills - American Heart Association (AHA) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Insulin Like Growth Factor -1 (IGFBP-1) is Pro-angiogenic and Enhances Hind Limb Perfusion in Insulin Resistant Mice

Natalie Haywood - American Heart Association (AHA) , 2017

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

Nitric oxide

Vascular Prostanoids Paradoxically Amplify Vasoconstriction During Platelet Activation

Jane A Mitchell - American Heart Association (AHA) , 2017

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved